en · de · es
analytical-notes.peptides5388.com › Blog › Background And Pharmacological Mechanism — 2026 Update

Background And Pharmacological Mechanism — 2026 Update

By Editorial Desk · published 2025-07-22 · last reviewed 2025-09-10 · Blog

The short version of LC-MS/MS fits in a sentence. The long version — which is the one that helps — is below.

This page was last updated on 2025-09-10 and is reviewed periodically as new material appears.

Background and Pharmacological Mechanism

SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.

SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.

Analytical Detection and Storage

Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.

Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.

Sr9009 at a glance

PropertyValueNotes
Molecular formulaC20H24ClN3O4SReported for the free base
Molecular weight437.9 g/molCalculated from the formula
Primary targetREV-ERBα and REV-ERBβNuclear receptors involved in circadian regulation
SolubilitySoluble in DMSO and ethanolPoorly soluble in water
Typical storage-20 °C, desiccatedProtect from light and moisture

Handling Storage and Quality Control

Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.

Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.

Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.

Related pages on this site

SR9009 Background and Mechanism

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.

In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.

SR9009 Handling and Quality Control

Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.

SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.

SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.

Analytical Detection and Laboratory Handling

Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.

In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.

Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.

Supporting material

The genetic code (the "translation table" according to which DNA information is translated into amino acids, and hence proteins) is nearly identical for all known lifeforms, from bacteria and archaea to animals and plants. The universality of this code is generally regarded by biologists as definitive evidence in favor of universal common descent. The way that codons (DNA triplets) are mapped to amino acids seems to be strongly optimised. Richard Egel argues that in particular the hydrophobic (non-polar) side-chains are well organised, suggesting that these enabled the earliest organisms to create peptides with water-repelling regions able to support the essential electron exchange (redox) reactions for energy transfer.

Le Havre is the birthplace of many musicians and composers such as Henri Woollett (1864–1936), André Caplet (1878–1925) and Arthur Honegger (1892–1955). There was also Victor Mustel (1815–1890) who was famous for having perfected the harmonium. Le Havre has long been regarded as one of the cradles of French rock and blues. In the 1980s many groups have emerged after a first dynamic development in the 1960s and 1970s. The most famous personality of Le Havre rock is Little Bob who began his career in the 1970s. The port tradition in many of the groups was repeated in the unused sheds of the port, such as Bovis hall which could hold 20,000 spectators. A blues festival, driven by Jean-François Skrobek, Blues a Gogo existed for eight years from 1995 to 2002. Several artists have been produced such as: Youssou N'Dour, Popa Chubby, Amadou & Mariam, Patrick Verbeke etc. It was organized by the Coup de Bleu association whose former president was head of music Café L'Agora in the Niemeyer Centre which produced the new Le Havre scene. During these same years, the Festival of the Future, the local version of the Fête de l'Humanité (Festival of Humanity), attracted a large audience. Currently, the musical tradition continues in the Symphony Orchestra of the city of Le Havre, the orchestra of Concerts André Caplet, the conservatory, and music schools such as the Centre for Vocal and Musical Expression (rock) or the JUPO (mainly jazz), associations or labels like Papa's Production (la Folie Ordinaire, Mob's et Travaux, Dominique Comont, Souinq, Your Happy End etc.).

In a series of publications in 1991–92, Michael Kastan of Johns Hopkins University, reported that TP53 was a critical part of a signal transduction pathway that helped cells respond to DNA damage. In 1993, p53 was voted molecule of the year by Science magazine.

=== Water treatment === Scale deposition in boilers can reduce heat transfer efficiency and increase energy consumption. Antiscalants are added to boiler feedwater to prevent scale formation on heat transfer surfaces, piping, and other boiler components. Water treatment plants can use antiscalants to maintain filtration.

== Research == In his research, White focused on membrane protein folding and stability, energetics of protein-bilayer interactions, experimentally determined hydrophobicity scales, translocon-assisted folding of membrane proteins, structure of fluid lipid bilayers, and MD simulations of lipid bilayers. His experimental expertise included X-ray diffraction, neutron diffraction, molecular dynamics simulations, calorimetry, physical chemistry, surface chemistry, statistical analysis of protein sequences, electrical impedance methods, planar bilayer methodology, peptide chemistry, and lipid chemistry. White’s lab determined the first fully resolved structure of a fluid lipid bilayer by combining x-ray and neutron diffraction data, and subsequently validated molecular dynamics simulations of fluid bilayers. White wrote a critical review of the principles of membrane folding and stability in 1999 that is among the ten most cited articles in Annual Review of Biophysics. Using a thermodynamic framework, he highlighted three main aspects of membrane protein folding energetics: protein binding and folding in bilayer interfaces, transmembrane helix insertion, and helix-helix interactions. In his paper “Mechanisms of Integral Membrane Protein Insertion and Folding” written in collaboration with Gunnar von Heijne, he evaluated the progress made during the past decade toward understanding translocon-assisted folding of membrane proteins and reviewed the role of basic thermodynamic principles in MP folding and assembly.

Sources: en.wikipedia.org

Notes from published material

Researchers in safety-critical AI have proposed using architectural redundancy and design diversity to reduce the risk that a single faulty, compromised, or deceptive model causes harm. In such approaches, multiple independently developed or trained models process the same task, and a voter or consensus mechanism combines their outputs rather than relying on a single model.

There are many methods to investigate protein–protein interactions which are the physical contacts of high specificity established between two or more protein molecules. This process typically involves electrostatic forces and hydrophobic effects. Each of the approaches has its own strengths and weaknesses, especially with regard to the sensitivity and specificity of the method. A high sensitivity means that many of the interactions that occur are detected by the screen. A high specificity indicates that most of the interactions detected by the screen are occurring in reality.

Polyendocrine metabolic ovarian syndrome (PMOS) is an endocrine disorder characterized by an excess of androgens produced by the ovaries. It is estimated that approximately 90% of women with PMOS demonstrate hypersecretion of these hormones. The cause of this condition is unknown. Speculations include genetic predisposition; however, the gene or genes responsible for this remain unidentified. The condition may have a hereditary basis. Other possible causes include elevated insulin production. Most cases of PMOS involve insulin resistance. It is thought that adipose tissue dysfunction plays a role in the insulin resistance seen in PMOS. Insulin can induce excess testosterone secretion from the ovaries. A complication associated with polyendocrine metabolic ovarian syndrome is high cholesterol, which is treated with statins. In a meta-analysis, atorvastatin was shown to decrease androgen concentrations in people with hyperandrogenism. Elevated insulin leads to lower production of sex hormone binding globulin (SHBG), a regulatory glycoprotein that suppresses the function of androgens. High blood levels of insulin also work in conjunction with ovarian sensitivity to insulin to cause hyperandrogenemia, the primary symptom of PMOS. Obese individuals may be more biologically inclined to PMOS due to markedly higher insulin. This hormonal imbalance can lead to chronic anovulation, in which the ovaries fail to release mature eggs. These cases of ovulatory dysfunction are linked to infertility and menstrual disturbances.

On 25 March 2024 Shehbaz Sharif reconstituted the eight-member Council of Common Interests (CCI) as chairman after a notification was issued. The Prime Minister inducted Khawaja Asif (Defense), Amir Muqam (SAFRON), and Ishaq Dar (Foreign Affairs) into the Council. The composition of the CCI marked the first time a foreign minister had been designated a member, replacing the membership of the finance minister. Abdullah Niazi an editor at Profit claimed that Muhammad Aurangzeb's role in the Cabinet was being undermined by Ishaq Dar, further remarking that the inclusion of Khwaja Asif and Engineer Amir Muqam might indicate Shehbaz Sharif's focus on giving party loyalists greater influence. According to Mushtaq Ghumman, finance ministers were not always included in the CCI however energy and planning ministers were. In the previous Pakistan Democratic Movement (PDM) government under Shehbaz Sharif the finance minister was not included in the CCI. Attaullah Tarar on March 29 would state that “nobody has been replaced or substituted," referencing the constitutional procedure of the CCI. Summaries submitted by different ministries and provincial governments were returned for later resubmission following the re-constitution of the Council. CCI Secretary Omer Rasul stated that the summaries forwarded by ministries, divisions and provincial governments did not conform with the guidelines demarcated in Rules of Procedure of CCI (2010) and were ambiguous whether such cases fell within the purview of the CCI.

Sources: en.wikipedia.org

Background from the literature

It is the over-expression of efflux pump proteins observed in resistant cancer cells that allows them to produce these pumps in high quantities and/or increase their overall activity compared to normal, sensitive cells. A specific protein and member of the ATP-binding cassette (ABC) transporter family known as p-glycoprotein (P-gp), has been suggested to play a major role in the development of resistance in cancer cells by promoting drug efflux. Research on P-gp and other related efflux pumps is currently ongoing, but studies have suggested that they have the capacity to transport various types of chemotherapeutic agents out of cancer cells resulting in a significantly reduced bioavailability of such drugs, and ultimately failed chemotherapy treatments. The inhibition of efflux pumps has been suggested as a promising therapeutic target to overcome this mechanism of resistance in cancer cells, aiming to both restore chemotherapeutic drug bioavailability within the cells, yet avoid deregulating normal functioning pumps and reduce undesired adverse effects. Conversely, toxic drug interactions have posed a major obstacle to successfully developing efflux pump inhibitors and highlights the difficulty of targeted chemotherapeutic drug formulation. Many proteins involved in intracellular transport processes have been identified as fundamental contributors of resistance by impairing chemotherapeutic drug-target interactions.

A Penning trap is a device for the storage of charged particles using a homogeneous magnetic field and a quadrupole electric field. It is mostly found in the physical sciences and related fields of study for precision measurements of properties of ions and stable subatomic particles, like for example mass, fission yields and isomeric yield ratios. One initial object of study was the so-called geonium atoms, which represent a way to measure the electron magnetic moment by storing a single electron. These traps have been used in the physical realization of quantum computation and quantum information processing by trapping qubits. Penning traps are in use in many laboratories worldwide, including CERN, to store and investigate anti-particles such as antiprotons. The main advantages of Penning traps are the potentially long storage times and the existence of a multitude of techniques to manipulate and non-destructively detect the stored particles. This makes Penning traps versatile for the investigation of stored particles, but also for their selection, preparation or mere storage.

== Pharmacodynamics == Levonantradol is a full CB1 receptor agonist. Cannabinoid receptors belong to the superfamily of G-protein coupled receptors (GPCRs), and endogenous cannabinoids naturally activate GPCRs. GPCRs modulate the inhibition of adenylyl cyclase and accumulation of the second messenger, cyclic adenosine monophosphate (cAMP). The CB1 receptor is the most common GPCR in the central nervous system. The activation of CB1Rs decrease calcium conductance and increase potassium conductance in the brain. CB signaling naturally modulates synaptic transmission and mediates psychoactivity, and synthetic cannabinoids mimic these same actions. Although the efficacy of Levonantradol is dependent on the level of GCPR activity, Full agonists like Levonantradol have the ability to activate GPCRs and convert Gα into a high affinity state for GTP or low affinity state for GDP. Previous studies suggest that Levonantradol has a higher binding affinity and efficacy than other similar synthetic cannabinoids (e.g. Δ9-THC).

Sources: en.wikipedia.org

Frequently asked questions

What is SR9009?

It is a synthetic REV-ERB agonist used mainly in preclinical research. It is not an approved medicine for human use.

How does it work?

It binds to REV-ERBα and REV-ERBβ, nuclear receptors involved in circadian and metabolic gene regulation. This can alter transcription of genes related to lipid and glucose metabolism in experimental models.

Is it proven to increase endurance in humans?

No controlled human trials have established that effect. Endurance findings come primarily from rodent studies, and human responses remain unknown.

How is SR9009 measured?

Liquid chromatography-tandem mass spectrometry is a common approach. It can detect the parent compound and its metabolites in biological matrices.

Network